[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Chen TK, Knicely DH, Grams ME
Mounjaro (tirzepatide) A newer medication that combines two hormones, GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), Tirzepatide (Mounjaro/Zepbound): Dual GIP/GLP-1 agonist
Contact your physician or go to the ER if you experience: Vomiting lasting more than 24 hours, preventing you from keeping fluids down Dehydration signs such as dizziness, dry mouth, rapid heartbeat, or dark urine Sharp, constant upper abdominal pain, especially if it radiates to your back Fever, jaundice (yellowing of the skin or eyes), or bloody vomit/stool Confusion, extreme fatigue, or fainting Most individuals can manage GLP-1 side effects at home, but knowing when to seek further care is essential
Conclusion We found evidence for the role of lower GSH in patients with MDD in the occipital region of the brain, a difference which is not found in other brain regions or in combined brain region studies
When asked about the drugs on McDonald's earnings conference call last month, CEO Chris Kempczinski touted the burger chain's existing protein options
So, with a dose specifically tailored to the patient, the weight comes off
